Population-based surveillance for hypertension awareness, treatment, and control in nine districts - India Hypertension Control Initiative, 2018–19
Hypertension control is the crucial indicator for cardiovascular disease programs. We conducted a baseline cross-sectional survey to estimate hypertension awareness, treatment, and control in the selected districts in 2018-19, where the India Hypertension Control Initiative is being implemented. We conducted cross-sectional surveys in nine project districts for 18-69 years age group. The sample size was 624 per district. The study population was individuals with raised BP/diagnosed HT. We estimated the proportion and 95% confidence intervals (CI) for each district's awareness, treatment, and control. We computed unadjusted and adjusted prevalence ratios (APR) with 95% CI for factors associated with BP control. Hypertension was defined as systolic blood pressure (SBP) > = 140 or diastolic blood pressure (DBP) > = 90 mmHg or treatment in the previous two weeks. Control was defined as SBP < 140 and DBP < 90 mmHg. Among 7047 who had hypertension, 52.4% were aware, 40.8% were on treatment, and 14.5% had BP control. BP control was below 5% in two districts, 5-15% in three districts, and more than 15% in four districts. Among hypertensives aware of the diagnosis, the factors (APR with 95% CI) associated with control were lack of alcohol consumption [1.28 (1.09-1.52)], recent visit to government [1.98 (1.57-2.50)] or private facility [1.99 (1.61-2.46)] and treatment with single drug [2.40 (1.98-2.90)] or multiple drugs [2.84 (2.27-3.55)]. The simple, rapid population-based surveys can document awareness, treatment, and control changes. Improving access to treatment for hypertension through the public or private sector should be a high priority for India.
Authors
- Bidisha Das
- Padmaja Jogewar
- Sandeep Singh Gill (ORCID: https://orcid.org/0000-0002-9151-8969)
- Ashish Saxsena
- Sampada Dipak Bangar (ORCID: https://orcid.org/0000-0002-4295-9856)
- Madhavi Mallela
- Vettrichelvan Venkatasamy (ORCID: https://orcid.org/0000-0001-5142-9673)
- Rupali Bharadwaj
- Chakshu Joshi
- Pooja Gaigaware
- Vishwajit Bharadwaj
- Yannick P. Puthussery
- Prabhdeep Kaur (ORCID: https://orcid.org/0000-0002-2605-3739)
- Anupam Khungar Pathni (ORCID: https://orcid.org/0000-0001-7582-0861)
- Sailaja Bitragunta
- Abhishek Kunwar
- Azhagendran Sivalingam
- Suyesh Shrivastava (ORCID: https://orcid.org/0000-0002-1311-7895)
- Sreedhar Chintala
- A. Gunasekaran (ORCID: https://orcid.org/0000-0002-5043-2149)
- Gopinath Thirugnana Sambandam
- Meenakshi Sharma (ORCID: https://orcid.org/0000-0002-9721-7104)
- R. Sabarinathan
- P Kamaraj (ORCID: https://orcid.org/0000-0001-8252-8404)
- Kiran Durgad
- Balram Bhargava (ORCID: https://orcid.org/0000-0002-1707-1361)
- Pankaj Uike
- Tapas Chakma (ORCID: https://orcid.org/0000-0001-8304-8816)
- Bipin Gopal
- RS Dhaliwal
Institutions
- Government of Maharashtra (IN)
- Government of Andhra Pradesh (IN)
- Government of Kerala (IN)
- Government of Uttar Pradesh (IN)
- Indian Council of Medical Research (IN)
- National Institute of Epidemiology (IN)
- National Institute for Research in Tribal Health (IN)
- National AIDS Research Institute (IN)
- World Health Organization - India (IN)
Publication Details
- Journal
- Journal of Human Hypertension
- Published
- 2025-03-22
- DOI
- https://doi.org/10.1038/s41371-025-01005-9
- Citations
- 5
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 6.94
Funders
- World Health Organization
- Indian Council of Medical Research
- Ministry of Health and Family Welfare
- Centers for Disease Control and Prevention